Definitive Healthcare Corp. Class A (DH)

Over the past six months, Definitive Healthcare Corp. stock has experienced events related to earnings reports and analyst ratings. In Q3 2025, the company reported EPS of $0.07, beating estimates, with revenue at $60.05 million, although total revenue was down 4% year-over-year. In Q2 2025, the company reported EPS of -$0.07. Analysts have maintained a consensus "hold" rating for DH stock. The stock's 52-week low was $1.93, and its 52-week high was $5.67, with a closing price of $1.97 as of February 6, 2026, and a -45.41% change over the past year. The company is estimated to report its Q4 and full-year 2025 financial results on Thursday, February 26, 2026.

The provided search results do not contain specific information regarding the demand seasonality for Definitive Healthcare Corp.'s products and services. The company primarily derives its revenue from subscription fees for access to its platform and stand-ready support. While the Q3 2025 earnings call mentioned that Q3 is a smaller renewal period in terms of volume of renewals, this does not provide a comprehensive picture of overall demand seasonality for their products and services.

Definitive Healthcare Corp. (DH) is a provider of healthcare commercial intelligence, operating within the Healthcare sector and the Health Information Services industry. The company offers a SaaS platform designed to provide comprehensive information on the U.S. healthcare ecosystem, assisting customers with product development, go-to-market planning, sales, and marketing execution. The company's major products include HospitalView and IDN profiles, PhysicianView and PhysicianGroupView, Monocl ExpertInsight, Population Intelligence, Atlas All-Payor & Prescription Claims, LongTermCareView, ClinicView, ImagingView, SurgeryCenterView, ConnectedCareView, and Digital Audiences. The company serves a diverse client base, including biopharmaceutical and medical device companies, healthcare information technology companies, healthcare providers, and other diversified companies within the healthcare ecosystem.

Definitive Healthcare Corp. is a global organization with offices in the U.S., Sweden, and India. The company derives the majority of its revenue from the United States. Its SaaS platform provides information on the healthcare ecosystem in the U.S. and internationally.

Information directly detailing Definitive Healthcare Corp.'s brand reputation in the past year is not explicitly available in the search results. However, the company positions itself as a provider of trusted intelligence and reliable data in the complex healthcare market, aiming to help customers make smarter, faster, and more strategic decisions. The company emphasizes its commitment to delivering reliable, actionable, and differentiated insights.

Definitive Healthcare Corp. has a mixed ownership structure, including institutional, retail, and individual investors. There are 228 institutional owners holding a total of 98,296,558 shares, with major shareholders including Advent International Corp/ma, Goldman Sachs Group Inc, and BlackRock, Inc.; Advent International LP holds a significant 60.5% of the equities. David Mussafer owns the most shares among individual investors, with Kevin Coop (CEO) directly owning 0.32% of the company's shares. Approximately 9.59% of the company's stock is owned by insiders.